PAVM Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-01-30 | Sparks Ronald M | director | 450,000 | A-Award | A | 450,000 | 0.48 | 216,000.00 |
| 2023-01-30 | Harvey Joan B | director | 450,000 | A-Award | A | 450,000 | 0.48 | 216,000.00 |
| 2023-01-30 | White Debra | director | 450,000 | A-Award | A | 450,000 | 0.48 | 216,000.00 |
| 2023-01-30 | Glennon Michael J | director | 450,000 | A-Award | A | 450,000 | 0.48 | 216,000.00 |
| 2023-01-30 | Baxter Timothy E | director | 450,000 | A-Award | A | 450,000 | 0.48 | 216,000.00 |
| 2023-01-30 | Cox James L | director | 450,000 | A-Award | A | 450,000 | 0.48 | 216,000.00 |
| 2022-12-07 | Glennon Michael J | director | 250,000 | P-Purchase | A | 100,000 | 0.62 | 62,320.00 |
| 2022-12-06 | Glennon Michael J | director | 150,000 | P-Purchase | A | 88,000 | 0.64 | 56,082.40 |
| 2022-12-05 | Glennon Michael J | director | 62,000 | P-Purchase | A | 62,000 | 0.69 | 42,606.40 |
| 2022-06-07 | Gordon Michael Adam | officer: General Counsel | 400,000 | A-Award | A | 400,000 | 0.97 | 388,000.00 |
| 2022-03-28 | Aklog Lishan | director, officer: Chairman and CEO | 176,277 | F-InKind | D | 79,636 | 1.18 | 93,970.48 |
| 2022-03-28 | MCGRATH DENNIS M | officer: President & CFO | 755,489 | F-InKind | D | 199,973 | 1.18 | 235,968.14 |
| 2022-02-22 | O'Neil Shaun | officer: Chief Operating Officer | 300,000 | A-Award | A | 300,000 | 1.48 | 444,000.00 |
| 2022-02-22 | O'Neil Shaun | officer: Chief Operating Officer | 150,000 | F-InKind | D | 75,000 | 2.43 | 182,250.00 |
| 2022-02-18 | Baxter Timothy E | director | 80,000 | A-Award | A | 80,000 | 1.59 | 127,200.00 |
| 2022-02-18 | Glennon Michael J | director | 80,000 | A-Award | A | 80,000 | 1.59 | 127,200.00 |
| 2022-02-18 | White Debra | director | 80,000 | A-Award | A | 80,000 | 1.59 | 127,200.00 |
| 2022-02-18 | DeGuzman Brian J. | officer: Chief Medical Officer | 50,000 | A-Award | A | 50,000 | 1.59 | 79,500.00 |
| 2022-02-18 | Cox James L | director | 80,000 | A-Award | A | 80,000 | 1.59 | 127,200.00 |
| 2022-02-18 | Sparks Ronald M | director | 80,000 | A-Award | A | 80,000 | 1.59 | 127,200.00 |
| 2022-02-18 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 200,000 | A-Award | A | 200,000 | 1.59 | 318,000.00 |
| 2022-02-18 | MCGRATH DENNIS M | officer: President & CFO | 150,000 | A-Award | A | 150,000 | 1.59 | 238,500.00 |
| 2022-02-11 | Harvey Joan B | director | 179,350 | A-Award | A | 179,350 | 2.05 | 367,667.50 |
| 2021-06-15 | Baxter Timothy E | director | 75,000 | A-Award | A | 75,000 | 5.79 | 434,250.00 |
| 2021-04-29 | White Debra | director | 100,000 | A-Award | A | 100,000 | 4.81 | 481,000.00 |
| 2021-04-01 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 1,255,913 | A-Award | A | 150,000 | 0.00 | 0.00 |
| 2021-04-01 | Cox James L | director | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2021-04-01 | Weild IV David | director | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2021-04-01 | DeGuzman Brian J. | officer: Chief Medical Officer | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2021-04-01 | Sparks Ronald M | director | 50,000 | A-Award | A | 50,000 | 4.44 | 222,000.00 |
| 2021-04-01 | MCGRATH DENNIS M | officer: President & CFO | 955,462 | A-Award | A | 150,000 | 0.00 | 0.00 |
| 2021-04-01 | Battleman David S. | director | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2021-04-01 | Glennon Michael J | director, officer: Vice Chairman | 50,000 | A-Award | A | 50,000 | 4.44 | 222,000.00 |
| 2021-03-18 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 1,105,913 | P-Purchase | A | 7,500 | 4.31 | 32,323.50 |
| 2020-11-25 | SIROVICH MATTHEW | 10 percent owner | 1,027,744 | S-Sale | D | 33,203 | 1.96 | 65,048.00 |
| 2020-11-24 | SIROVICH MATTHEW | 10 percent owner | 1,060,947 | S-Sale | D | 53,036 | 2.00 | 105,875.77 |
| 2020-11-19 | SIROVICH MATTHEW | 10 percent owner | 1,113,983 | S-Sale | D | 75,211 | 1.83 | 137,418.02 |
| 2020-11-18 | SIROVICH MATTHEW | 10 percent owner | 1,189,194 | S-Sale | D | 24,789 | 1.78 | 44,164.08 |
| 2020-05-29 | SIROVICH MATTHEW | 10 percent owner | 1,213,983 | S-Sale | D | 131,082 | 1.98 | 259,476.82 |
| 2020-05-28 | SIROVICH MATTHEW | 10 percent owner | 1,345,065 | S-Sale | D | 69,839 | 2.06 | 143,665.81 |
| 2020-04-30 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 1,098,413 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2020-04-30 | Sparks Ronald M | director | 100,000 | A-Award | A | 100,000 | 2.19 | 219,000.00 |
| 2020-04-30 | DeGuzman Brian J. | officer: Chief Medical Officer | 50,000 | A-Award | A | 50,000 | 2.19 | 109,500.00 |
| 2020-04-30 | Weild IV David | director | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2020-04-30 | Glennon Michael J | director, officer: Vice Chairman | 100,000 | A-Award | A | 100,000 | 2.19 | 219,000.00 |
| 2020-04-30 | Battleman David S. | director | 100,000 | A-Award | A | 100,000 | 2.19 | 219,000.00 |
| 2020-04-30 | MCGRATH DENNIS M | officer: President & CFO | 791,704 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2020-04-30 | Cox James L | director | 100,000 | A-Award | A | 100,000 | 2.19 | 219,000.00 |
| 2020-01-30 | SIROVICH MATTHEW | 10 percent owner | 1,938,297 | X-InTheMoney | A | 1,199,383 | 0.01 | 11,993.83 |
| 2020-01-30 | SIROVICH MATTHEW | 10 percent owner | 0 | X-InTheMoney | D | 1,199,383 | 0.01 | 11,993.83 |
| 2019-05-24 | MCGRATH DENNIS M | officer: President & CFO | 529,000 | P-Purchase | A | 5,000 | 1.09 | 5,428.50 |
| 2019-05-23 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 848,413 | P-Purchase | A | 30,000 | 1.10 | 32,850.00 |
| 2019-03-15 | MCGRATH DENNIS M | officer: President & CFO | 524,000 | A-Award | A | 500,000 | 0.00 | 0.00 |
| 2019-03-15 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 818,413 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2019-03-07 | DeGuzman Brian J. | officer: Chief Medical Officer | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2019-03-07 | Cox James L | director | 200,000 | A-Award | A | 200,000 | 1.00 | 200,000.00 |
| 2019-03-07 | Battleman David S. | director | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2019-03-07 | Glennon Michael J | director, officer: Vice Chairman | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2019-03-07 | Sparks Ronald M | director | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2019-03-07 | Weild IV David | director | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2018-12-27 | SIROVICH MATTHEW | 10 percent owner | 738,914 | J-Other | A | 272,400 | 0.00 | 0.00 |
| 2018-12-27 | SIROVICH MATTHEW | 10 percent owner | 792,000 | J-Other | A | 60,000 | 0.00 | 0.00 |
| 2018-08-28 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 618,413 | P-Purchase | A | 30,000 | 1.18 | 35,400.00 |
| 2018-06-26 | DeGuzman Brian J. | officer: Chief Medical Officer | 322,673 | J-Other | A | 322,673 | 1.60 | 516,276.80 |
| 2018-06-26 | DeGuzman Brian J. | officer: Chief Medical Officer | 0 | J-Other | D | 322,673 | 1.60 | 516,276.80 |
| 2018-06-26 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 2,078,285 | J-Other | A | 968,019 | 0.00 | 0.00 |
| 2018-06-26 | Glennon Michael J | director, officer: Vice Chairman | 322,673 | J-Other | A | 322,673 | 1.60 | 516,276.80 |
| 2018-06-26 | Glennon Michael J | director, officer: Vice Chairman | 0 | J-Other | D | 322,673 | 1.60 | 516,276.80 |
| 2018-06-12 | MCGRATH DENNIS M | officer: President & CFO | 24,000 | X-InTheMoney | A | 12,000 | 1.60 | 19,200.00 |
| 2018-06-12 | MCGRATH DENNIS M | officer: President & CFO | 0 | X-InTheMoney | D | 12,000 | 1.60 | 19,200.00 |
| 2018-06-12 | MCGRATH DENNIS M | officer: President & CFO | 12,000 | X-InTheMoney | A | 12,000 | 1.60 | 19,200.00 |
| 2018-06-12 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 2,303 | X-InTheMoney | A | 1,018 | 0.00 | 0.00 |
| 2018-06-12 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 2,280 | X-InTheMoney | A | 980 | 0.00 | 0.00 |
| 2018-06-12 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 0 | X-InTheMoney | D | 1,018 | 0.00 | 0.00 |
| 2018-06-12 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 1,018 | X-InTheMoney | A | 1,018 | 0.00 | 0.00 |
| 2018-06-12 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 980 | X-InTheMoney | A | 980 | 0.00 | 0.00 |
| 2018-06-08 | Greenspan Ira Scott | 10 percent owner | 421,691 | S-Sale | D | 18,300 | 1.04 | 19,032.00 |
| 2018-06-01 | Greenspan Ira Scott | 10 percent owner | 439,991 | S-Sale | D | 532,255 | 0.97 | 516,287.35 |
| 2018-04-20 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 363,313 | G-Gift | D | 12,450 | 1.60 | 19,920.00 |
| 2018-04-05 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 0 | D-Return | D | 50,450 | 5.00 | 252,250.00 |
| 2018-04-05 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 25,225 | A-Award | A | 25,225 | 0.00 | 0.00 |
| 2018-04-05 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 2,823,281 | A-Award | A | 2,823,281 | 0.00 | 0.00 |
| 2018-04-05 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 1,110,266 | A-Award | A | 1,110,266 | 0.00 | 0.00 |
| 2018-04-05 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 10,000 | A-Award | A | 10,000 | 0.00 | 0.00 |
| 2018-02-14 | Cox James L | director | 100,000 | A-Award | A | 100,000 | 2.01 | 201,000.00 |
| 2018-02-14 | Weild IV David | director | 100,000 | A-Award | A | 100,000 | 2.01 | 201,000.00 |
| 2018-02-14 | Battleman David S. | director | 100,000 | A-Award | A | 100,000 | 2.01 | 201,000.00 |
| 2018-02-14 | Sparks Ronald M | director | 100,000 | A-Award | A | 100,000 | 2.01 | 201,000.00 |
| 2018-02-14 | DeGuzman Brian J. | officer: Chief Medical Officer | 100,000 | A-Award | A | 100,000 | 2.01 | 201,000.00 |
| 2018-02-14 | MCGRATH DENNIS M | officer: President & CFO | 195,108 | A-Award | A | 195,108 | 2.01 | 392,167.08 |
| 2018-02-14 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 195,108 | A-Award | A | 195,108 | 2.01 | 392,167.08 |
| 2018-02-14 | Glennon Michael J | director, officer: Vice Chairman | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2018-02-02 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 588,413 | G-Gift | D | 34,153 | 0.00 | 0.00 |
| 2017-12-22 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 622,566 | G-Gift | D | 150,000 | 0.00 | 0.00 |
| 2017-12-21 | Glennon Michael J | director, officer: Vice Chairman | 645,346 | J-Other | A | 645,346 | 0.00 | 0.00 |
| 2017-12-21 | Glennon Michael J | director, officer: Vice Chairman | 0 | J-Other | D | 645,346 | 0.00 | 0.00 |
| 2017-12-21 | Lamstein Joshua R | director | 163,177 | J-Other | A | 79,560 | 0.00 | 0.00 |
| 2017-12-21 | DeGuzman Brian J. | officer: Chief Medical Officer | 645,346 | J-Other | A | 645,346 | 0.00 | 0.00 |
| 2017-12-21 | DeGuzman Brian J. | officer: Chief Medical Officer | 0 | J-Other | D | 645,346 | 0.00 | 0.00 |
| 2017-12-21 | Aklog Lishan | director, 10 percent owner, officer: Chairman and CEO | 0 | J-Other | D | 5,646,562 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.